AWM
JAZZ icon

AE Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

AE Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$586K Buy
3,100
+369
+14% +$64.5K ﹤0.01% 1027
2025
Q4 		$464K Buy
2,731
+64
+2% +$9.81K ﹤0.01% 1087
2025
Q3 		$352K Buy
2,667
+162
+6% +$19.4K ﹤0.01% 1115
2025
Q2 		$266K Sell
2,505
-25
-1% -$2.72K ﹤0.01% 1162
2025
Q1 		$314K Sell
2,530
-763
-23% -$99.5K ﹤0.01% 1067
2024
Q4 		$406K Buy
3,293
+698
+27% +$82.3K ﹤0.01% 975
2024
Q3 		$289K Buy
2,595
+62
+2% +$6.79K ﹤0.01% 1043
2024
Q2 		$270K Buy
+2,533
New +$278K ﹤0.01% 1064
2020
Q4 		– Sell
-3,871
Closed -$552K – 1391
2020
Q3 		$552K Buy
+3,871
New +$480K 0.01% 851
2020
Q2 		– Sell
-3,816
Closed -$381K – 1310
2020
Q1 		$381K Buy
+3,816
New +$493K 0.01% 780

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AE Wealth Management's JAZZ Position: Q1 2026 in Review

AE Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 14% in Q1 2026, buying an estimated $64.5K and bringing the position to 3,100 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

AE Wealth Management first reported a position in JAZZ in Q1 2020 and has held it in 10 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • AE Wealth Management held 3,100 shares of Jazz Pharmaceuticals worth $586K as of Q1 2026.
  • AE Wealth Management bought 369 Jazz Pharmaceuticals shares in Q1 2026, an estimated $64.5K.
  • Jazz Pharmaceuticals made up ﹤0.01% of AE Wealth Management's portfolio in Q1 2026, its #1027 holding.
  • AE Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 10 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.